NRX Pharmaceuticals NRXP Insider Ownership

NASDAQ NRXP
$2.40 -0.23 (-8.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

Insider Holdings by Owner

3.46Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
3.66%
■0% pp QoQ
Shares Held by Insiders
1.58Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
43.16Mn
43,157,744 shares
Direct Holdings
141.81K
Indirect: 1.44Mn
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
7
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Updated

Across the past 12 months, NRX Pharmaceuticals insiders reported no open-market purchases or sales.

Form 4 Holdings

Insiders Holding NRXP

Insiders 7
Shares held 3.46Mn
Of outstanding 8.01%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Daniel C. Javitt TenPercentOwner 0 1,950,769 1,950,769 56.4% 01 Dec, 2022
2 Jonathan C Javitt Chairman And Chief Scientist 84,634 1,290,000 1,374,634 39.8% 17 Dec, 2024
3 Chaim Hurvitz Director 107,000 0 107,000 3.1% 11 Sep, 2023
4 Aaron Gorovitz Director 0 10,500 10,500 0.3% 11 Sep, 2023
5 Stephen H Willard Chief Executive Officer 5,000 0 5,000 0.1% 18 Dec, 2022
6 Voorhees Seth Van Chief Financial Officer 4,634 0 4,634 0.1% 18 Dec, 2022
7 Patrick John Flynn Director 175 4,021 4,196 0.1% 28 Nov, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

96 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
27 Jan, 2026 Joseph Michael Casper Chief Operating Officer Acquired A 100,000 $0.00 $0 100,000 Direct
07 Feb, 2025 Michael S Abrams Chief Financial Officer Acquired A 50,000 $0.00 $0 50,000 Direct
17 Dec, 2024 Jonathan C Javitt Chairman And Chief Scientist Acquired P 40,000 $1.17 $46.80K 84,634 Direct
30 Aug, 2023 Chaim Hurvitz Director Acquired P 70,000 $2.88 $201.25K 57,000 Direct
30 Aug, 2023 Aaron Gorovitz Director Acquired P 35,000 $3.20 $111.97K 10,500 Indirect
23 Aug, 2023 Jonathan C Javitt Chief Scientist Acquired P 100,000 $3.30 $330.00K 44,633 Direct
22 Aug, 2023 Jonathan C Javitt Chief Scientist Acquired P 200,000 $3.22 $644.00K 34,633 Direct
16 Dec, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 30,000 $11.00 $330.00K 4,634 Direct
16 Dec, 2022 Stephen H Willard Chief Executive Officer Acquired P 50,000 $11.70 $585.00K 5,000 Direct
25 Nov, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 8,716 $11.20 $97.62K 872 Direct
25 Nov, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 600 $11.00 $6.60K 932 Direct
25 Nov, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 7,021 $11.10 $77.93K 1,634 Direct
07 Dec, 2022 Jonathan C Javitt Director, TenPercentOwner Disposed S 400,000 $10.00 $4.00Mn 1,290,000 Indirect
29 Nov, 2022 Daniel C. Javitt TenPercentOwner Disposed S 13,730 $15.04 $206.51K 964,323 Indirect
30 Nov, 2022 Daniel C. Javitt TenPercentOwner Disposed S 8,441 $15.05 $127.00K 963,479 Indirect
25 Nov, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 8,716 $11.20 $97.62K 872 Indirect
28 Nov, 2022 Patrick John Flynn Director Acquired P 2,500 $12.50 $31.25K 3,771 Indirect
28 Nov, 2022 Patrick John Flynn Director Acquired P 2,500 $12.50 $31.25K 4,021 Indirect
25 Nov, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 600 $11.00 $6.60K 932 Indirect
25 Nov, 2022 Voorhees Seth Van Chief Financial Officer Acquired P 7,021 $11.10 $77.93K 1,638 Indirect